A Research Study Looking at How Safe it is to Switch From Emicizumab to Mim8 in People With Haemophilia A (FRONTIER 5)
Clinical trial NCT05878938 · COMPLETED
Trial details
- NCT number
- NCT05878938
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-26
- Primary completion
- 2024-07-18
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.